Home › Funds › Yiheng Capital Management, L.P. › KYMR

Yiheng Capital Management, L.P. position in KYMR

KYMERA THERAPEUTICS INC · Health Care

Yiheng Capital Management, L.P. reported holding 63,440 shares of KYMR (KYMERA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$7.1M, representing 2.75% of its reported portfolio and ranking #13 among its reported holdings. Yiheng Capital Management, L.P. has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

Latest position (Q3 2026)63.44K sh
Reported value held$7.09M
Portfolio Weight2.75%
First reportedQ1 2025
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Yiheng Capital Management, L.P.'s KYMR position evolved

Yiheng Capital Management, L.P. first disclosed a stake in KYMR in Q1 2025 at 122,605 shares (US$3.4M). The position peaked in Q2 2026 at 63,440 shares, worth US$7.3M. Across 7 filings, Yiheng Capital Management, L.P. increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 63,440 shares valued at US$7.1M. Notable position changes include a 40% trim in Q4 2025 (shares rose 7% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 122.61K $3.36M New
Q2 2025 122.61K $5.35M Hold
Q3 2025 122.61K $6.94M Hold
Q4 2025 73.44K $5.71M Reduce
Q1 2026 73.44K $6.12M Hold
Q2 2026 63.44K $7.27M Reduce
Q3 2026 63.44K $7.09M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KYMR and 13F data

KYMR (KYMERA THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in KYMR — the largest reported positions include BAKER BROS. ADVISORS LP (US$992.7M), Avoro Capital Advisors LLC (US$835.6M), T. Rowe Price Investment Management, Inc. (US$717.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KYMR

All KYMR fund holders →

FAQ

How long has Yiheng Capital Management, L.P. held KYMR?

Yiheng Capital Management, L.P. has disclosed KYMR holdings in 7 of the last 7 reported quarters, going back to Q1 2025.

What is Yiheng Capital Management, L.P.'s current position in KYMR?

As of Q3 2026, Yiheng Capital Management, L.P. holds 63.44K shares of KYMR (KYMERA THERAPEUTICS INC), valued at $7.09M, representing 2.75% of its reported portfolio and ranking #13.

Has Yiheng Capital Management, L.P. been buying or selling KYMR?

In the latest 13F filing (Q3 2026), Yiheng Capital Management, L.P. held unchanged its position in KYMR. The position peaked in Q2 2026 at 63.44K shares.

Which other funds hold KYMR?

Other major institutional holders of KYMR include BAKER BROS. ADVISORS LP, Avoro Capital Advisors LLC, T. Rowe Price Investment Management, Inc., among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.